Balsammedica Sp. z o.o.
- Address
- Ul. Goleszowska 1/U5, 01-249 Warsaw, Poland
Cardiovascular Diseases
At Balsammedica Sp. z o.o. in Warsaw, clinical research in cardiovascular diseases focuses on hypertension and related heart health concerns. These studies are designed to assess whether new treatment approaches can better control blood pressure and support care for people with excess weight or obesity.
- Evaluating a new therapy approach for hypertension in adults with obesity or overweight
- Studying the safety and effectiveness of treatment strategies aimed at improving blood pressure control
This work reflects a broader effort to improve long-term management of cardiovascular conditions through better treatment options and stronger evidence on patient outcomes.
Respiratory Tract Diseases
Research at this site also includes respiratory tract diseases, with a focus on non-permanent atrial fibrillation and its associated health risks. The trial activity is centered on evaluating whether a new therapy can help reduce episode recurrence while maintaining an acceptable safety profile.
- Assessing treatment safety and tolerability for non-permanent atrial fibrillation
- Examining how well the therapy helps prevent return of irregular heart rhythm episodes
These studies are intended to expand understanding of treatment effectiveness in cardiac rhythm disorders and support better care for people living with this condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Balsammedica Sp. z o.o.
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Budiodarone in Subjects with Non-permanent Atrial Fibrillation | Xyra LLC | Phase IV | Recruiting | Jul 2026 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 3 | Unknown | 2024-10-18 | 2025-10-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.